Bromoacetamido-PEG-NHS ester is a chemical compound that belongs to the family of polyethylene glycol (PEG) derivatives. This compound contains functional groups such as bromine, acetamide, and NHS ester. These functional groups make Bromoacetamido-PEG-NHS ester highly versatile and useful in a variety of applications, especially in drug research and development.
In drug development, Bromoacetamido-PEG-NHS ester is commonly used as a linker molecule for the conjugation of drugs to targeting moieties such as antibodies, peptides, or proteins. The NHS ester functional group allows for efficient conjugation with primary amines present on the targeting moieties, while the PEG chain provides water solubility and biocompatibility to the resulting conjugate.
Furthermore, the bromine and acetamide functional groups on Bromoacetamido-PEG-NHS ester allow for additional chemical modifications such as cross-linking, immobilization, or surface functionalization of biomolecules. These modifications can further enhance the efficacy, stability, and bioavailability of the resulting drug product.
Bromoacetamido-PEG-NHS ester is a highly versatile and valuable compound in drug research and development due to its unique combination of functional groups. Its use as a linker molecule for drug conjugation provides a promising strategy for targeted drug delivery and personalized medicine.
|AP12016||3-(2-bromoacetamido)propanoic acid NHS ester||307.1||≥95%||Pricing|